Use of fenoldopam to increase urine output in a patient with renal insufficiency secondary to septic shock: A case report

Pediatric Critical Care Medicine

Volumn 7, Issue 6, 2006, Pages 600-602

  Moffett, Brady S ^a   Orellana, Renán ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Diuretics; Fenoldopam; Heart failure; Oliguria; Sepsis

Indexed keywords

ANTIINFECTIVE AGENT; FENOLDOPAM; FUROSEMIDE; HYPERTENSIVE AGENT; INOTROPIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; DRUG EFFECT; DRUG INFUSION; DRUG MECHANISM; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; KIDNEY FAILURE; MALE; OLIGURIA; PRIORITY JOURNAL; SEPTIC SHOCK; TREATMENT RESPONSE; URINE VOLUME;

ADOLESCENT; DIURETICS; FENOLDOPAM; HUMANS; INTENSIVE CARE UNITS, PEDIATRIC; MALE; OLIGURIA; RENAL INSUFFICIENCY, ACUTE; SHOCK, SEPTIC;

EID: 33750814316     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000244406.98058.9A     Document Type: Article

References (15)

1. Morelli A, Ricci Z, Bellomo R, et al: Prophylactic fenoldopam for renal protection in sepsis: A randomized, double-blind, placebo-controlled pilot trial. Crit Care Med 2005; 33:2451-2456
2. Kleinknecht D, Landais P, Brivet F, et al: Prognosis and mortality in patients with multiple organ system failure. French Study Group on Acute Renal Failure. Ren Fail 1996; 18:347-353
3. Halpenny M, Lakshmi S, O'Donnell A, et al: Fenoldopam: Renal and splanchnic effects in patients undergoing coronary artery bypass grafting. Anaesthesia 2001; 56:953-960
4. Murphy MB, Murray C, Shorten GD: Fenoldopam: A selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med 2001; 345:1548-1557
5. Lokhandwala MF: Preclinical and clinical studies on the cardiovascular and renal effects of fenoldopam: A DA-1 receptor agonist. Drug Devel Res 1987a; 10:123-134
6. Tumlin JA, Finkel KW, Murray PT, et al: Fenoldopam mesylate in early acute tubular necrosis: A randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis 2005; 46:26-34
7. Halpenny M, Rushe C, Breen P, et al: The effects of fenoldopam on renal function in patients undergoing elective aortic surgery. Eur J Anaesthesiol 2002; 19:32-39
8. Ranucci M, Soro G, Barzaghi N, et al: Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients. Ann Thorac Surg 2004; 78:1332-1337; discussion 1337-1338
9. Caimmi PP, Pagani L, Micalizzi E, et al: Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2003; 17:491-494
10. Bove T, Landoni G, Calabro MG, et al: Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: A prospective, double-blind, randomized clinical trial. Circulation 2005; 111:3230-3235
11. Strauser LM, Pruitt RD, Tobias JD: Initial experience with fenoldopam in children. Am J Ther 1999; 6:283-288
12. Tobias JD: Controlled hypotension in children: A critical review of available agents. Paediatr Drugs 2002; 4:439-453
13. Lechner BL, Pascual JF, Roscelli JD: Failure of fenoldopam to control severe hypertension secondary to renal graft rejection in a pediatric patient. Mil Med 2005; 170:130-132
14. Costello JM, Thiagarajan RR, Dionne RE, et al: Initial experience with fenoldopam after cardiac surgery in neonates with an insufficient response to conventional diuretics. Pediatr Crit Care Med 2006; 7:28-33
15. Kellum JA: Prophylactic fenoldopam for renal protection? No, thank you, not for me - Not yet at least. Crit Care Med 2005; 33:2681-2683